Crosstalk between organs is crucial for controlling numerous homeostatic systems (e.g. energy balance, glucose metabolism and immunity). Several pathological conditions, such as obesity and type 2 diabetes, are characterised by a loss of or excessive inter-organ communication that contributes to the development of disease. Recently, we and others have identified several mechanisms linking the gut microbiota with the development of obesity and associated disorders (e.g. insulin resistance, type 2 diabetes, hepatic steatosis). Among these, we described the concept of metabolic endotoxaemia (increase in plasma lipopolysaccharide levels) as one of the triggering factors leading to the development of metabolic inflammation and insulin resistance. Growing evidence suggests that gut microbes contribute to the onset of low-grade inflammation characterising these metabolic disorders via mechanisms associated with gut barrier dysfunctions. We have demonstrated that enteroendocrine cells (producing glucagon-like peptide-1, peptide YY and glucagon-like peptide-2) and the endocannabinoid system control gut permeability and metabolic endotoxaemia. Recently, we hypothesised that specific metabolic dysregulations occurring at the level of numerous organs (e.g. gut, adipose tissue, muscles, liver and brain) rely from gut microbiota modifications. In this review, we discuss the mechanisms linking gut permeability, adipose tissue metabolism, and glucose homeostasis, and recent findings that show interactions between the gut microbiota, the endocannabinoid system and the apelinergic system. These specific systems are discussed in the context of the gut-to-peripheral organ axis (intestine, adipose tissue and brain) and impacts on metabolic regulation. In the present review, we also briefly describe the impact of a variety of non-digestible nutrients (i.e. inulin-type fructans, arabinoxylans, chitin glucans and polyphenols). Their effects on the composition of the gut microbiota and activity are discussed in the context of obesity and type 2 diabetes.
Alhamoruni, A., Wright, K.L., Larvin, M. and O’Sullivan, S.E., 2012. Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability. British Journal of Pharmacology 165: 2598-2610.
'Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability ' () 165 British Journal of Pharmacology : 2598 -2610.
Angelakis, E., Armougom, F., Million, M. and Raoult, D., 2012. The relationship between gut microbiota and weight gain in humans. Future Microbiology 7: 91-109.
'The relationship between gut microbiota and weight gain in humans ' () 7 Future Microbiology : 91 -109.
Backhed, F., Ding, H., Wang, T., Hooper, L.V., Koh, G.Y., Nagy, A., Semenkovich, C.F. and Gordon, J.I., 2004. The gut microbiota as an environmental factor that regulates fat storage. Proceedings of the National Academy of Sciences of the USA 101: 15718-15723.
'The gut microbiota as an environmental factor that regulates fat storage ' () 101 Proceedings of the National Academy of Sciences of the USA : 15718 -15723.
Backhed, F., Manchester, J.K., Semenkovich, C.F. and Gordon, J.I., 2007. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proceedings of the National Academy of Sciences of the USA 104: 979-984.
'Mechanisms underlying the resistance to diet-induced obesity in germ-free mice ' () 104 Proceedings of the National Academy of Sciences of the USA : 979 -984.
Basu, A. and Penugonda, K., 2009. Pomegranate juice: a heart-healthy fruit juice. Nutrition Reviews 67: 49-56.
'Pomegranate juice: a heart-healthy fruit juice ' () 67 Nutrition Reviews : 49 -56.
Bays, H.E., Evans, J.L., Maki, K.C., Evans, M., Maquet, V., Cooper, R. and Anderson, J.W., 2013. Chitin-glucan fiber effects on oxidized low-density lipoprotein: a randomized controlled trial. European Journal of Clinical Nutrition 67: 2-7.
'Chitin-glucan fiber effects on oxidized low-density lipoprotein: a randomized controlled trial ' () 67 European Journal of Clinical Nutrition : 2 -7.
Bensaid, M., Gary-Bobo, M., Esclangon, A., Maffrand, J.P., Le, F.G., Oury-Donat, F. and Soubrie, P., 2003. The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Molecular Pharmacology 63: 908-914.
'The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells ' () 63 Molecular Pharmacology : 908 -914.
Bialonska, D., Ramnani, P., Kasimsetty, S.G., Muntha, K.R., Gibson, G.R. and Ferreira, D., 2010. The influence of pomegranate by-product and punicalagins on selected groups of human intestinal microbiota. International Journal of Food Microbiology 140: 175-182.
'The influence of pomegranate by-product and punicalagins on selected groups of human intestinal microbiota ' () 140 International Journal of Food Microbiology : 175 -182.
Bird, A.R., Conlon, M.A., Christophersen, C.T. and Topping, D.L., 2010. Resistant starch, large bowel fermentation and a broader perspective of prebiotics and probiotics. Beneficial Microbes 1: 423-431.
'Resistant starch, large bowel fermentation and a broader perspective of prebiotics and probiotics ' () 1 Beneficial Microbes : 423 -431.
Bluher, M., Engeli, S., Kloting, N., Berndt, J., Fasshauer, M., Batkai, S., Pacher, P., Schon, M.R., Jordan, J. and Stumvoll, M., 2006. Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes 55: 3053-3060.
'Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity ' () 55 Diabetes : 3053 -3060.
Boesten, R.J. and De Vos, W.M., 2008. Interactomics in the human intestine: lactobacilli and bifidobacteria make a difference. Journal of Clinical Gastroenterology 42 Suppl. 3 Part 2: S163-S167.
'Interactomics in the human intestine: lactobacilli and bifidobacteria make a difference ' () 42 Journal of Clinical Gastroenterology : S163 -S167.
Boesten, R.J., Schuren, F.H. and De Vos, W.M., 2009. A Bifidobacterium mixed-species microarray for high resolution discrimination between intestinal bifidobacteria. Journal of Microbiological Methods 76: 269-277.
'A Bifidobacterium mixed-species microarray for high resolution discrimination between intestinal bifidobacteria ' () 76 Journal of Microbiological Methods : 269 -277.
Broekaert, W.F., Courtin, C.M., Verbeke, K., Van de Wiele, T., Verstraete, W. and Delcour, J.A., 2011. Prebiotic and other health-related effects of cereal-derived arabinoxylans, arabinoxylan-oligosaccharides, and xylooligosaccharides. Critical Reviews in Food Science and Nutrition 51: 178-194.
'Prebiotic and other health-related effects of cereal-derived arabinoxylans, arabinoxylan-oligosaccharides, and xylooligosaccharides ' () 51 Critical Reviews in Food Science and Nutrition : 178 -194.
Brun, P., Castagliuolo, I., Leo, V.D., Buda, A., Pinzani, M., Palu, G. and Martines, D., 2007. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. American Journal of Physiology - Gastrointestinal and Liver Physiology 292: G518-G525.
'Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis ' () 292 American Journal of Physiology - Gastrointestinal and Liver Physiology : G518 -G525.
Cani, P.D. and Delzenne, N.M., 2009. The role of the gut microbiota in energy metabolism and metabolic disease. Current Pharmaceutical Design 15: 1546-1558.
'The role of the gut microbiota in energy metabolism and metabolic disease ' () 15 Current Pharmaceutical Design : 1546 -1558.
Cani, P.D., Amar, J., Iglesias, M.A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A.M., Fava, F., Tuohy, K.M., Chabo, C., Waget, A., Delmee, E., Cousin, B., Sulpice, T., Chamontin, B., Ferrieres, J., Tanti, J.F., Gibson, G.R., Casteilla, L., Delzenne, N.M., Alessi, M.C. and Burcelin, R., 2007a. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761-1772.
'Metabolic endotoxemia initiates obesity and insulin resistance ' () 56 Diabetes : 1761 -1772.
Cani, P.D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A.M., Delzenne, N.M. and Burcelin, R., 2008. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57: 1470-1481.
'Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice ' () 57 Diabetes : 1470 -1481.
Cani, P.D., Daubioul, C.A., Reusens, B., Remacle, C., Catillon, G. and Delzenne, N.M., 2005a. Involvement of endogenous glucagon-like peptide-1(7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats. Journal of Endocrinology 185: 457-465.
'Involvement of endogenous glucagon-like peptide-1(7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats ' () 185 Journal of Endocrinology : 457 -465.
Cani, P.D., Joly, E., Horsmans, Y. and Delzenne, N.M., 2006a. Oligofructose promotes satiety in healthy human: a pilot study. European Journal of Clinical Nutrition 60: 567-572.
'Oligofructose promotes satiety in healthy human: a pilot study ' () 60 European Journal of Clinical Nutrition : 567 -572.
Cani, P.D., Knauf, C., Iglesias, M.A., Drucker, D.J., Delzenne, N.M. and Burcelin, R., 2006b. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes 55: 1484-1490.
'Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor ' () 55 Diabetes : 1484 -1490.
Cani, P.D., Lecourt, E., Dewulf, E.M., Sohet, F.M., Pachikian, B.D., Naslain, D., De, B.F., Neyrinck, A.M. and Delzenne, N.M., 2009a. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. The American Journal of Clinical Nutrition 90: 1236-1243.
'Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal ' () 90 The American Journal of Clinical Nutrition : 1236 -1243.
Cani, P.D., Neyrinck, A.M., Fava, F., Knauf, C., Burcelin, R.G., Tuohy, K.M., Gibson, G.R. and Delzenne, N.M., 2007b. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50: 2374-2383.
'Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia ' () 50 Diabetologia : 2374 -2383.
Cani, P.D., Neyrinck, A.M., Maton, N. and Delzenne, N.M., 2005b. Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like peptide-1. Obesity Research 13: 1000-1007.
'Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like peptide-1 ' () 13 Obesity Research : 1000 -1007.
Cani, P.D., Osto, M., Geurts, L. and Everard, A., 2012. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 3: 279-288.
'Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity ' () 3 Gut Microbes : 279 -288.
Cani, P.D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A.M., Lambert, D.M., Muccioli, G.G. and Delzenne, N.M., 2009b. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58: 1091-1103.
'Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability ' () 58 Gut : 1091 -1103.
Castan-Laurell, I., Dray, C., Attane, C., Duparc, T., Knauf, C. and Valet, P., 2011. Apelin, diabetes, and obesity. Endocrine 40: 1-9.
'Apelin, diabetes, and obesity ' () 40 Endocrine : 1 -9.
Castan-Laurell, I., Dray, C., Knauf, C., Kunduzova, O. and Valet, P., 2012. Apelin, a promising target for type 2 diabetes treatment? Trends in Endocrinology and Metabolism 23: 234-241.
'Apelin, a promising target for type 2 diabetes treatment? ' () 23 Trends in Endocrinology and Metabolism : 234 -241.
Clarke, S.F., Murphy, E.F., Nilaweera, K., Ross, P.R., Shanahan, F., O’Toole, P.W. and Cotter, P.D., 2012. The gut microbiota and its relationship to diet and obesity: new insights. Gut Microbes 3: 186-202.
'The gut microbiota and its relationship to diet and obesity: new insights ' () 3 Gut Microbes : 186 -202.
Cloetens, L., Broekaert, W.F., Delaedt, Y., Ollevier, F., Courtin, C.M., Delcour, J.A., Rutgeerts, P. and Verbeke, K., 2010. Tolerance of arabinoxylan-oligosaccharides and their prebiotic activity in healthy subjects: a randomised, placebo-controlled cross-over study. British Journal of Nutrition 103: 703-713.
'Tolerance of arabinoxylan-oligosaccharides and their prebiotic activity in healthy subjects: a randomised, placebo-controlled cross-over study ' () 103 British Journal of Nutrition : 703 -713.
Cluny, N.L., Reimer, R.A. and Sharkey, K.A., 2012. Cannabinoid signalling regulates inflammation and energy balance: the importance of the brain-gut axis. Brain, Behavior, and Immunity 26: 691-698.
'Cannabinoid signalling regulates inflammation and energy balance: the importance of the brain-gut axis ' () 26 Brain, Behavior, and Immunity : 691 -698.
Collado, M.C., Isolauri, E., Laitinen, K. and Salminen, S., 2008. Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. The American Journal of Clinical Nutrition 88: 894-899.
'Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women ' () 88 The American Journal of Clinical Nutrition : 894 -899.
Cota, D., Marsicano, G., Tschop, M., Grubler, Y., Flachskamm, C., Schubert, M., Auer, D., Yassouridis, A., Thone-Reineke, C., Ortmann, S., Tomassoni, F., Cervino, C., Nisoli, E., Linthorst, A.C., Pasquali, R., Lutz, B., Stalla, G.K. and Pagotto, U., 2003. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. The Journal of Clinical Investigation 112: 423-431.
'The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis ' () 112 The Journal of Clinical Investigation : 423 -431.
Dao, T.M., Waget, A., Klopp, P., Serino, M., Vachoux, C., Pechere, L., Drucker, D.J., Champion, S., Barthelemy, S., Barra, Y., Burcelin, R. and Seree, E., 2011. Resveratrol increases glucose induced GLP-1 secretion in mice: a mechanism which contributes to the glycemic control. PLoS ONE 6: e20700.
'Resveratrol increases glucose induced GLP-1 secretion in mice: a mechanism which contributes to the glycemic control ' () 6 PLoS ONE : e20700.
Daviaud, D., Boucher, J., Gesta, S., Dray, C., Guigne, C., Quilliot, D., Ayav, A., Ziegler, O., Carpene, C., Saulnier-Blache, J.S., Valet, P. and Castan-Laurell, I., 2006. TNFalpha up-regulates apelin expression in human and mouse adipose tissue. FASEB Journal 20: 1528-1530.
'TNFalpha up-regulates apelin expression in human and mouse adipose tissue ' () 20 FASEB Journal : 1528 -1530.
Davis, L.M., Martinez, I., Walter, J., Goin, C. and Hutkins, R.W., 2011. Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans. PLoS ONE 6: e25200.
'Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans ' () 6 PLoS ONE : e25200.
Delzenne, N.M. and Cani, P.D., 2005. A place for dietary fibre in the management of the metabolic syndrome. Current Opinion in Clinical Nutrition and Metabolic Care 8: 636-640.
'A place for dietary fibre in the management of the metabolic syndrome ' () 8 Current Opinion in Clinical Nutrition and Metabolic Care : 636 -640.
Delzenne, N.M., Neyrinck, A.M., Backhed, F. and Cani, P.D., 2011. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nature Reviews Endocrinology 7: 639-646.
'Targeting gut microbiota in obesity: effects of prebiotics and probiotics ' () 7 Nature Reviews Endocrinology : 639 -646.
Dewulf, E.M., Cani, P.D., Claus, S.P., Fuentes, S., Puylaert, P.G., Neyrinck, A.M., Bindels, L.B., De Vos, W.M., Gibson, G.R., Thissen, J.P. and Delzenne, N.M., 2013. Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 62: 1112-1121.
'Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women ' () 62 Gut : 1112 -1121.
Dewulf, E.M., Cani, P.D., Neyrinck, A.M., Possemiers, S., Holle, A.V., Muccioli, G.G., Deldicque, L., Bindels, L.B., Pachikian, B.D., Sohet, F.M., Mignolet, E., Francaux, M., Larondelle, Y. and Delzenne, N.M., 2011. Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARgamma-related adipogenesis in the white adipose tissue of high-fat diet-fed mice. Journal of Nutritional Biochemistry 22: 712-722.
'Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARgamma-related adipogenesis in the white adipose tissue of high-fat diet-fed mice ' () 22 Journal of Nutritional Biochemistry : 712 -722.
Ding, S., Chi, M.M., Scull, B.P., Rigby, R., Schwerbrock, N.M., Magness, S., Jobin, C. and Lund, P.K., 2010. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS ONE 5: e12191.
'High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse ' () 5 PLoS ONE : e12191.
Dray, C., Debard, C., Jager, J., Disse, E., Daviaud, D., Martin, P., Attane, C., Wanecq, E., Guigne, C., Bost, F., Tanti, J.F., Laville, M., Vidal, H., Valet, P. and Castan-Laurell, I., 2010. Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans. American Journal of Physiology - Endocrinology and Metabolism 298: E1161-E1169.
'Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans ' () 298 American Journal of Physiology - Endocrinology and Metabolism : E1161 -E1169.
Dray, C., Knauf, C., Daviaud, D., Waget, A., Boucher, J., Buleon, M., Cani, P.D., Attane, C., Guigne, C., Carpene, C., Burcelin, R., Castan- Laurell, I. and Valet, P., 2008. Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metabolism 8: 437-445.
'Apelin stimulates glucose utilization in normal and obese insulin-resistant mice ' () 8 Cell Metabolism : 437 -445.
Dube, P.E. and Brubaker, P.L., 2007. Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators. American Journal of Physiology - Endocrinology and Metabolism 293: E460-E465.
'Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators ' () 293 American Journal of Physiology - Endocrinology and Metabolism : E460 -E465.
Duparc, T., Colom, A., Cani, P.D., Massaly, N., Rastrelli, S., Drougard, A., Le, G.S., Mouledous, L., Frances, B., Leclercq, I., Llorens-Cortes, C., Pospisilik, J.A., Delzenne, N.M., Valet, P., Castan-Laurell, I. and Knauf, C., 2011a. Central apelin controls glucose homeostasis via a nitric oxide-dependent pathway in mice. Antioxidants and Redox Signaling 15: 1477-1496.
'Central apelin controls glucose homeostasis via a nitric oxide-dependent pathway in mice ' () 15 Antioxidants and Redox Signaling : 1477 -1496.
Duparc, T., Naslain, D., Colom, A., Muccioli, G.G., Massaly, N., Delzenne, N.M., Valet, P., Cani, P.D. and Knauf, C., 2011b. Jejunum inflammation in obese and diabetic mice impairs enteric glucose detection and modifies nitric oxide release in the hypothalamus. Antioxidants and Redox Signaling 14: 415-423.
'Jejunum inflammation in obese and diabetic mice impairs enteric glucose detection and modifies nitric oxide release in the hypothalamus ' () 14 Antioxidants and Redox Signaling : 415 -423.
Eckel, R.H., Grundy, S.M. and Zimmet, P.Z., 2005. The metabolic syndrome. The Lancet 365: 1415-1428.
'The metabolic syndrome ' () 365 The Lancet : 1415 -1428.
Engeli, S., 2012. Central and peripheral cannabinoid receptors as therapeutic targets in the control of food intake and body weight. In: Joost, H.-G. (ed.) Appetite control. Handbook of experimental pharmacology Vol. 209. Springer, Berlin, Germany, pp. 357-381.
Appetite control. Handbook of experimental pharmacology , () 357 -381.
Engeli, S., Bohnke, J., Feldpausch, M., Gorzelniak, K., Janke, J., Batkai, S., Pacher, P., Harvey-White, J., Luft, F.C., Sharma, A.M. and Jordan, J., 2005. Activation of the peripheral endocannabinoid system in human obesity. Diabetes 54: 2838-2843.
'Activation of the peripheral endocannabinoid system in human obesity ' () 54 Diabetes : 2838 -2843.
Erdem, G., Dogru, T., Tasci, I., Sonmez, A. and Tapan, S., 2008. Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus. Experimental and Clinical Endocrinology and Diabetes 116: 289-292.
'Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus ' () 116 Experimental and Clinical Endocrinology and Diabetes : 289 -292.
Everard, A., Lazarevic, V., Derrien, M., Girard, M., Muccioli, G.M., Neyrinck, A.M., Possemiers, S., Van, H.A., Francois, P., De Vos, W.M., Delzenne, N.M., Schrenzel, J. and Cani, P.D., 2011. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 60: 2775-2786.
'Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice ' () 60 Diabetes : 2775 -2786.
Flint, H.J., 2012. The impact of nutrition on the human microbiome. Nutrition Reviews 70 Suppl. 1: S10-S13.
'The impact of nutrition on the human microbiome ' () 70 Nutrition Reviews : S10 -S13.
Galic, S., Oakhill, J.S. and Steinberg, G.R., 2010. Adipose tissue as an endocrine organ. Molecular and Cellular Endocrinology 316: 129-139.
'Adipose tissue as an endocrine organ ' () 316 Molecular and Cellular Endocrinology : 129 -139.
Gary-Bobo, M., Elachouri, G., Gallas, J.F., Janiak, P., Marini, P., Ravinet- Trillou, C., Chabbert, M., Cruccioli, N., Pfersdorff, C., Roque, C., Arnone, M., Croci, T., Soubrie, P., Oury-Donat, F., Maffrand, J.P., Scatton, B., Lacheretz, F., Le, F.G., Herbert, J.M. and Bensaid, M., 2007. Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats. Hepatology 46: 122-129.
'Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats ' () 46 Hepatology : 122 -129.
Ge, Q., Maury, E., Rycken, L., Gerard, J., Noel, L., Detry, R., Navez, B. and Brichard, S.M., 2013. Endocannabinoids regulate adipokine production and the immune balance of omental adipose tissue in human obesity. International Journal of Obesity 37: 874-880.
'Endocannabinoids regulate adipokine production and the immune balance of omental adipose tissue in human obesity ' () 37 International Journal of Obesity : 874 -880.
Geurts, L., Lazarevic, V., Derrien, M., Everard, A., Van Roye, M., Knauf, C., Valet, P., Girard, M., Muccioli, G.G., Francois, P., De Vos, W.M., Delzenne, N.M. and Cani, P.D., 2011. Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue. Frontiers in Microbiology 2: 149.
'Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue ' () 2 Frontiers in Microbiology : 149.
Grootaert, C., Van den Abbeele, P., Marzorati, M., Broekaert, W.F., Courtin, C.M., Delcour, J.A., Verstraete, W. and Van de Wiele, T., 2009. Comparison of prebiotic effects of arabinoxylan oligosaccharides and inulin in a simulator of the human intestinal microbial ecosystem. Fems Microbiology and Ecology 69: 231-242.
'Comparison of prebiotic effects of arabinoxylan oligosaccharides and inulin in a simulator of the human intestinal microbial ecosystem ' () 69 Fems Microbiology and Ecology : 231 -242.
Gustafson, B., Gogg, S., Hedjazifar, S., Jenndahl, L., Hammarstedt, A. and Smith, U., 2009. Inflammation and impaired adipogenesis in hypertrophic obesity in man. American Journal of Physiology - Endocrinology and Metabolism 297: E999-E1003.
'Inflammation and impaired adipogenesis in hypertrophic obesity in man ' () 297 American Journal of Physiology - Endocrinology and Metabolism : E999 -E1003.
Han, S., Wang, G., Qi, X., Englander, E.W. and Greeley Jr., G.H., 2008. Involvement of a Stat3 binding site in inflammation-induced enteric apelin expression. American Journal of Physiology - Gastrointestinal and Liver Physiology 295: G1068-G1078.
'Involvement of a Stat3 binding site in inflammation-induced enteric apelin expression ' () 295 American Journal of Physiology - Gastrointestinal and Liver Physiology : G1068 -G1078.
Hansen, C.H., Krych, L., Nielsen, D.S., Vogensen, F.K., Hansen, L.H., Sorensen, S.J., Buschard, K. and Hansen, A.K., 2012. Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse. Diabetologia 55: 2285-2294.
'Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse ' () 55 Diabetologia : 2285 -2294.
Hoareau, L., Buyse, M., Festy, F., Ravanan, P., Gonthier, M.P., Matias, I., Petrosino, S., Tallet, F., d’Hellencourt, C.L., Cesari, M., Di, M.V. and Roche, R., 2009. Anti-inflammatory effect of palmitoylethanolamide on human adipocytes. Obesity 17: 431-438.
'Anti-inflammatory effect of palmitoylethanolamide on human adipocytes ' () 17 Obesity : 431 -438.
Hotamisligil, G.S., 2008. Inflammation and endoplasmic reticulum stress in obesity and diabetes. International Journal Obesity 32 Suppl. 7: S52-S54.
'Inflammation and endoplasmic reticulum stress in obesity and diabetes ' () 32 International Journal Obesity : S52 -S54.
Johanningsmeier, S.D. and Harris, G.K., 2011. Pomegranate as a functional food and nutraceutical source. Annual Review of Food Science and Technology 2: 181-201.
'Pomegranate as a functional food and nutraceutical source ' () 2 Annual Review of Food Science and Technology : 181 -201.
Kalliomaki, M., Collado, M.C., Salminen, S. and Isolauri, E., 2008. Early differences in fecal microbiota composition in children may predict overweight. The American Journal of Clinical Nutrition 87: 534-538.
'Early differences in fecal microbiota composition in children may predict overweight ' () 87 The American Journal of Clinical Nutrition : 534 -538.
Karlsson, C.L., Onnerfalt, J., Xu, J., Molin, G., Ahrne, S. and Thorngren-Jerneck, K., 2012. The microbiota of the gut in preschool children with normal and excessive body weight. Obesity 20: 2257-2261.
'The microbiota of the gut in preschool children with normal and excessive body weight ' () 20 Obesity : 2257 -2261.
Lambert, D.M. and, Muccioli, G.G., 2007. Endocannabinoids and related N-acylethanolamines in the control of appetite and energy metabolism: emergence of new molecular players. Current Opinion in Clinical Nutrition and Metabolic Care 10: 735-744.
'Endocannabinoids and related N-acylethanolamines in the control of appetite and energy metabolism: emergence of new molecular players ' () 10 Current Opinion in Clinical Nutrition and Metabolic Care : 735 -744.
Ley, R.E., 2010. Obesity and the human microbiome. Current Opinion in Gastroenterology 26: 5-11.
'Obesity and the human microbiome ' () 26 Current Opinion in Gastroenterology : 5 -11.
Liu, J., Batkai, S., Pacher, P., Harvey-White, J., Wagner, J.A., Cravatt, B.F., Gao, B. and Kunos, G., 2003. Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/ phosphoinositide 3-kinase/NF-kappaB independently of platelet-activating factor. The Journal of Biological Chemistry 278: 45034-45039.
'Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/ phosphoinositide 3-kinase/NF-kappaB independently of platelet-activating factor ' () 278 The Journal of Biological Chemistry : 45034 -45039.
Lv, S.Y., Yang, Y.J., Qin, Y.J., Mo, J.R., Wang, N.B., Wang, Y.J. and Chen, Q., 2012. Central apelin-13 inhibits food intake via the CRF receptor in mice. Peptides 33: 132-138.
'Central apelin-13 inhibits food intake via the CRF receptor in mice ' () 33 Peptides : 132 -138.
Maccarrone, M., De, P.L., Bari, M., Fezza, F., Salvati, S., Di, M.V. and Finazzi-Agro, A., 2001. Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes. Archives in Biochemistry and Biophysics 393: 321-328.
'Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes ' () 393 Archives in Biochemistry and Biophysics : 321 -328.
Macfarlane, G.T., Steed, H. and Macfarlane, S., 2008. Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. Journal of Applied Microbiology 104: 305-344.
'Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics ' () 104 Journal of Applied Microbiology : 305 -344.
Maenhaut, N. and Van, d.V., 2011. Regulation of vascular tone by adipocytes. BMC Medicine 9: 25.
'Regulation of vascular tone by adipocytes ' () 9 BMC Medicine : 25.
Maki, K.C., Gibson, G.R., Dickmann, R.S., Kendall, C.W., Chen, C.Y., Costabile, A., Comelli, E.M., McKay, D.L., Almeida, N.G., Jenkins, D., Zello, G.A. and Blumberg, J.B., 2012. Digestive and physiologic effects of a wheat bran extract, arabino-xylan-oligosaccharide, in breakfast cereal. Nutrition 28: 1115-1121.
'Digestive and physiologic effects of a wheat bran extract, arabino-xylan-oligosaccharide, in breakfast cereal ' () 28 Nutrition : 1115 -1121.
Matias, I. and Di Marzo,V., 2007. Endocannabinoids and the control of energy balance. Trends in Endocrinology and Metabolism 18: 27-37.
'Endocannabinoids and the control of energy balance ' () 18 Trends in Endocrinology and Metabolism : 27 -37.
Melgar-Lesmes, P., Pauta, M., Reichenbach, V., Casals, G., Ros, J., Bataller, R., Morales-Ruiz, M. and Jimenez, W., 2011. Hypoxia and proinflammatory factors upregulate apelin receptor expression in human stellate cells and hepatocytes. Gut 60: 1404-1411.
'Hypoxia and proinflammatory factors upregulate apelin receptor expression in human stellate cells and hepatocytes ' () 60 Gut : 1404 -1411.
Mestdagh, R., Dumas, M.E., Rezzi, S., Kochhar, S., Holmes, E., Claus, S.P. and Nicholson, J.K., 2011. Gut microbiota modulate the metabolism of brown adipose tissue in mice. Journal of Proteome Research 11: 620-630.
'Gut microbiota modulate the metabolism of brown adipose tissue in mice ' () 11 Journal of Proteome Research : 620 -630.
Moore, W.E. and Moore, L.H., 1995. Intestinal floras of populations that have a high risk of colon cancer. Applied and Environmental Microbiology 61: 3202-3207.
'Intestinal floras of populations that have a high risk of colon cancer ' () 61 Applied and Environmental Microbiology : 3202 -3207.
Muccioli, G.G., 2010. Endocannabinoid biosynthesis and inactivation, from simple to complex. Drug Discovery Today 15: 474-483.
'Endocannabinoid biosynthesis and inactivation, from simple to complex ' () 15 Drug Discovery Today : 474 -483.
Muccioli, G.G., Naslain, D., Backhed, F., Reigstad, C.S., Lambert, D.M., Delzenne, N.M. and Cani, P.D., 2010. The endocannabinoid system links gut microbiota to adipogenesis. Molecular Systems Biology 6: 392.
'The endocannabinoid system links gut microbiota to adipogenesis ' () 6 Molecular Systems Biology : 392.
Musso, G., Gambino, R. and Cassader, M., 2010. Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders. Current Opinion in Lipidology 21: 76-83.
'Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders ' () 21 Current Opinion in Lipidology : 76 -83.
Neyrinck, A.M. and Delzenne, N.M., 2010. Potential interest of gut microbial changes induced by non-digestible carbohydrates of wheat in the management of obesity and related disorders. Current Opinion in Clinical Nutrition and Metabolic Care 13: 722-728.
'Potential interest of gut microbial changes induced by non-digestible carbohydrates of wheat in the management of obesity and related disorders ' () 13 Current Opinion in Clinical Nutrition and Metabolic Care : 722 -728.
Neyrinck, A.M., Possemiers, S., Druart, C., Van de Wiele, T., De, B.F., Cani, P.D., Larondelle, Y. and Delzenne, N.M., 2011. Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice. PLoS ONE 6: e20944.
'Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice ' () 6 PLoS ONE : e20944.
Neyrinck, A.M., Possemiers, S., Verstraete, W., De Backer, F., Cani, P.D. and Delzenne, N.M., 2012a. Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin-glucan fiber improves host metabolic alterations induced by high-fat diet in mice. Journal of Nutritional Biochemistry 23: 51-59.
'Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin-glucan fiber improves host metabolic alterations induced by high-fat diet in mice ' () 23 Journal of Nutritional Biochemistry : 51 -59.
Neyrinck, A.M., Van Hee, V.F., Bindels, L.B., De Backer, F., Cani, P.D. and Delzenne, N.M., 2013. Polyphenol-rich extract of pomegranate peel alleviates tissue inflammation and hypercholesterolaemia in high-fat diet-induced obese mice: potential implication of the gut microbiota. British Journal of Nutrition 109: 802-809.
'Polyphenol-rich extract of pomegranate peel alleviates tissue inflammation and hypercholesterolaemia in high-fat diet-induced obese mice: potential implication of the gut microbiota ' () 109 British Journal of Nutrition : 802 -809.
Neyrinck, A.M., Van Hee, V.F., Piront, N., De Backer, F., Toussaint, O., Cani, P.D. and Delzenne, N.M., 2012b. Wheat-derived arabinoxylan oligosaccharides with prebiotic effect increase satietogenic gut peptides and reduce metabolic endotoxemia in diet-induced obese mice. Nutrition and Diabetes 2: e28.
'Wheat-derived arabinoxylan oligosaccharides with prebiotic effect increase satietogenic gut peptides and reduce metabolic endotoxemia in diet-induced obese mice ' () 2 Nutrition and Diabetes : e28.
Ogden, C.L., Yanovski, S.Z., Carroll, M.D. and Flegal, K.M., 2007. The epidemiology of obesity. Gastroenterology 132: 2087-2102.
'The epidemiology of obesity ' () 132 Gastroenterology : 2087 -2102.
Pagotto, U., Marsicano, G., Cota, D., Lutz, B. and Pasquali, R., 2006. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocrine Reviews 27: 73-100.
'The emerging role of the endocannabinoid system in endocrine regulation and energy balance ' () 27 Endocrine Reviews : 73 -100.
Parkar, S.G., Stevenson, D.E. and Skinner, M.A., 2008. The potential influence of fruit polyphenols on colonic microflora and human gut health. International Journal of Food Microbiology 124: 295-298.
'The potential influence of fruit polyphenols on colonic microflora and human gut health ' () 124 International Journal of Food Microbiology : 295 -298.
Parnell, J.A. and Reimer, R.A., 2012. Prebiotic fibres dose-dependently increase satiety hormones and alter Bacteroidetes and Firmicutes in lean and obese JCR:LA-cp rats. British Journal of Nutrition 107: 601-613.
'Prebiotic fibres dose-dependently increase satiety hormones and alter Bacteroidetes and Firmicutes in lean and obese JCR:LA-cp rats ' () 107 British Journal of Nutrition : 601 -613.
Pertwee, R.G., 2010. Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists. Current Medicinal Chemistry 17: 1360-1381.
'Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists ' () 17 Current Medicinal Chemistry : 1360 -1381.
Poulain-Godefroy, O., Lecoeur, C., Pattou, F., Fruhbeck, G. and Froguel, P., 2008. Inflammation is associated with a decrease of lipogenic factors in omental fat in women. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 295: R1-R7.
'Inflammation is associated with a decrease of lipogenic factors in omental fat in women ' () 295 American Journal of Physiology - Regulatory, Integrative and Comparative Physiology : R1 -R7.
Rabot, S., Membrez, M., Bruneau, A., Gerard, P., Harach, T., Moser, M., Raymond, F., Mansourian, R. and Chou, C.J., 2010. Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism. FASEB Journal 24: 4948-4959.
'Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism ' () 24 FASEB Journal : 4948 -4959.
Ravinet, T.C., Delgorge, C., Menet, C., Arnone, M. and Soubrie, P., 2004. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. International Journal of Obesity and Related Metabolic Disorders 28: 640-648.
'CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity ' () 28 International Journal of Obesity and Related Metabolic Disorders : 640 -648.
Reaux, A., Gallatz, K., Palkovits, M. and Llorens-Cortes, C., 2002. Distribution of apelin-synthesizing neurons in the adult rat brain. Neuroscience 113: 653-662.
'Distribution of apelin-synthesizing neurons in the adult rat brain ' () 113 Neuroscience : 653 -662.
Reaux-Le Goazigo, A., Bodineau, L., De Mota, N., Jeandel, L., Chartrel, N., Knauf, C., Raad, C., Valet, P. and Llorens-Cortes, C., 2011. Apelin and the proopiomelanocortin system: a new regulatory pathway of hypothalamic alpha-MSH release. American Journal of Physiology - Endocrinology and Metabolism 301: E955-E966.
'Apelin and the proopiomelanocortin system: a new regulatory pathway of hypothalamic alpha-MSH release ' () 301 American Journal of Physiology - Endocrinology and Metabolism : E955 -E966.
Roberfroid, M., 2007. Prebiotics: the concept revisited. Journal of Nutrion 137: 830S-837S.
'Prebiotics: the concept revisited ' () 137 Journal of Nutrion : 830S -837S.
Roberfroid, M., Gibson, G.R., Hoyles, L., McCartney, A.L., Rastall, R., Rowland, I., Wolvers, D., Watzl, B., Szajewska, H., Stahl, B., Guarner, F., Respondek, F., Whelan, K., Coxam, V., Davicco, M.J., Leotoing, L., Wittrant, Y., Delzenne, N.M., Cani, P.D., Neyrinck, A.M. and Meheust, A., 2010. Prebiotic effects: metabolic and health benefits. British Journal of Nutrition 104: S1-S63.
'Prebiotic effects: metabolic and health benefits ' () 104 British Journal of Nutrition : S1 -S63.
Robertson, M.D., 2012. Dietary-resistant starch and glucose metabolism. Current Opinion in Clinical Nutrition and Metabolic Care 15: 362-367.
'Dietary-resistant starch and glucose metabolism ' () 15 Current Opinion in Clinical Nutrition and Metabolic Care : 362 -367.
Rousseaux, C., Thuru, X., Gelot, A., Barnich, N., Neut, C., Dubuquoy, L., Dubuquoy, C., Merour, E., Geboes, K., Chamaillard, M., Ouwehand, A., Leyer, G., Carcano, D., Colombel, J.F., Ardid, D. and Desreumaux, P., 2007. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nature Medicine 13: 35-37.
'Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors ' () 13 Nature Medicine : 35 -37.
Ryberg, E., Larsson, N., Sjogren, S., Hjorth, S., Hermansson, N.O., Leonova, J., Elebring, T., Nilsson, K., Drmota, T. and Greasley, P.J., 2007. The orphan receptor GPR55 is a novel cannabinoid receptor. British Journal of Pharmacology 152: 1092-1101.
'The orphan receptor GPR55 is a novel cannabinoid receptor ' () 152 British Journal of Pharmacology : 1092 -1101.
Samuel, B.S., Shaito, A., Motoike, T., Rey, F.E., Backhed, F., Manchester, J.K., Hammer, R.E., Williams, S.C., Crowley, J., Yanagisawa, M. and Gordon, J.I., 2008. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proceedings of the National Academy of Sciences of the USA 105: 16767-16772.
'Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41 ' () 105 Proceedings of the National Academy of Sciences of the USA : 16767 -16772.
Santacruz, A., Collado, M.C., Garcia-Valdes, L., Segura, M.T., Martin- Lagos, J.A., Anjos, T., Marti-Romero, M., Lopez, R.M., Florido, J., Campoy, C. and Sanz, Y., 2010. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. British Journal of Nutrition 104: 83-92.
'Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women ' () 104 British Journal of Nutrition : 83 -92.
Selma, M.V., Espin, J.C. and Tomas-Barberan, F.A., 2009. Interaction between phenolics and gut microbiota: role in human health. Journal of Agricultural and Food Chemistry 57: 6485-6501.
'Interaction between phenolics and gut microbiota: role in human health ' () 57 Journal of Agricultural and Food Chemistry : 6485 -6501.
Serino, M., Luche, E., Gres, S., Baylac, A., Berge, M., Cenac, C., Waget, A., Klopp, P., Iacovoni, J., Klopp, C., Mariette, J., Bouchez, O., Lluch, J., Ouarne, F., Monsan, P., Valet, P., Roques, C., Amar, J., Bouloumie, A., Theodorou, V. and Burcelin, R., 2012. Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut 61: 543-553.
'Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota ' () 61 Gut : 543 -553.
Shen, J., Obin, M.S. and Zhao, L., 2012. The gut microbiota, obesity and insulin resistance. Molecular Aspects of Medicine 34: 39-58.
'The gut microbiota, obesity and insulin resistance ' () 34 Molecular Aspects of Medicine : 39 -58.
Shen, L., Keenan, M.J., Martin, R.J., Tulley, R.T., Raggio, A.M., McCutcheon, K.L. and Zhou, J., 2009. Dietary resistant starch increases hypothalamic POMC expression in rats. Obesity 17: 40-45.
'Dietary resistant starch increases hypothalamic POMC expression in rats ' () 17 Obesity : 40 -45.
Shoelson, S.E. and Goldfine, A.B., 2009. Getting away from glucose: fanning the flames of obesity-induced inflammation. Nature Medicine 15: 373-374.
'Getting away from glucose: fanning the flames of obesity-induced inflammation ' () 15 Nature Medicine : 373 -374.
Slavin, J.L., 2005. Dietary fiber and body weight. Nutrition 21: 411-418.
'Dietary fiber and body weight ' () 21 Nutrition : 411 -418.
Slavin, J.L., Savarino, V., Paredes-Diaz, A. and Fotopoulos, G., 2009. A review of the role of soluble fiber in health with specific reference to wheat dextrin. Journal of International Medical Research 37: 1-17.
'A review of the role of soluble fiber in health with specific reference to wheat dextrin ' () 37 Journal of International Medical Research : 1 -17.
Soriguer, F., Garrido-Sanchez, L., Garcia-Serrano, S., Garcia-Almeida, J.M., Garcia-Arnes, J., Tinahones, F.J. and Garcia-Fuentes, E., 2009. Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus. Obesity Surgery 19: 1574-1580.
'Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus ' () 19 Obesity Surgery : 1574 -1580.
Sorli, S.C., Van den Berghe, L., Masri, B., Knibiehler, B. and Audigier, Y., 2006. Therapeutic potential of interfering with apelin signalling. Drug Discovery Today 11: 1100-1106.
'Therapeutic potential of interfering with apelin signalling ' () 11 Drug Discovery Today : 1100 -1106.
Tam, J., Vemuri, V.K., Liu, J., Batkai, S., Mukhopadhyay, B., Godlewski, G., Osei-Hyiaman, D., Ohnuma, S., Ambudkar, S.V., Pickel, J., Makriyannis, A. and Kunos, G., 2010. Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity. Journal of Clinical Investigation 120: 2953-2966.
'Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity ' () 120 Journal of Clinical Investigation : 2953 -2966.
Tilg, H. and Kaser, A., 2011. Gut microbiome, obesity, and metabolic dysfunction. Journal of Clinical Investigation 121: 2126-2132.
'Gut microbiome, obesity, and metabolic dysfunction ' () 121 Journal of Clinical Investigation : 2126 -2132.
Tremaroli, V. and Backhed, F., 2012. Functional interactions between the gut microbiota and host metabolism. Nature 489: 242-249.
'Functional interactions between the gut microbiota and host metabolism ' () 489 Nature : 242 -249.
Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R. and Gordon, J.I., 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1031.
'An obesity-associated gut microbiome with increased capacity for energy harvest ' () 444 Nature : 1027 -1031.
Turroni, F., Foroni, E., Pizzetti, P., Giubellini, V., Ribbera, A., Merusi, P., Cagnasso, P., Bizzarri, B., De’Angelis, G.L., Shanahan, F., Van Sinderen, D. and Ventura, M., 2009. Exploring the diversity of the bifidobacterial population in the human intestinal tract. Applied and Environmental Microbiology 75: 1534-1545.
'Exploring the diversity of the bifidobacterial population in the human intestinal tract ' () 75 Applied and Environmental Microbiology : 1534 -1545.
Tzounis, X., Vulevic, J., Kuhnle, G.G., George, T., Leonczak, J., Gibson, G.R., Kwik-Uribe, C. and Spencer, J.P., 2008. Flavanol monomer-induced changes to the human faecal microflora. British Journal of Nutrition 99: 782-792.
'Flavanol monomer-induced changes to the human faecal microflora ' () 99 British Journal of Nutrition : 782 -792.
Van Gaal, L.F., Rissanen, A.M., Scheen, A.J., Ziegler, O. and Rossner, S., 2005. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. The Lancet 365: 1389-1397.
'Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study ' () 365 The Lancet : 1389 -1397.
Vincent, M., Philippe, E., Everard, A., Kassis, N., Rouch, C., Denom, J., Takeda, Y., Uchiyama, S., Delzenne, N.M., Cani, P.D., Migrenne, S. and Magnan, C., 2013. Dietary supplementation with Agaricus blazei Murill extract prevents diet-induced obesity and insulin resistance in rats. Obesity 21: 553-561.
'Dietary supplementation with Agaricus blazei Murill extract prevents diet-induced obesity and insulin resistance in rats ' () 21 Obesity : 553 -561.
Walton, G.E., Van den Heuvel, E.G. Kosters, M.H., Rastall, R.A., Tuohy, K.M. and Gibson, G.R., 2012. A randomised crossover study investigating the effects of galacto-oligosaccharides on the faecal microbiota in men and women over 50 years of age. British Journal of Nutrition 107: 1466-1475.
'A randomised crossover study investigating the effects of galacto-oligosaccharides on the faecal microbiota in men and women over 50 years of age ' () 107 British Journal of Nutrition : 1466 -1475.
Wu, X., Ma, C., Han, L., Nawaz, M., Gao, F., Zhang, X., Yu, P., Zhao, C., Li, L., Zhou, A., Wang, J., Moore, J.E., Millar, B.C. and Xu, J., 2010. Molecular characterisation of the faecal microbiota in patients with type II diabetes. Current Microbiology 61: 69-78.
'Molecular characterisation of the faecal microbiota in patients with type II diabetes ' () 61 Current Microbiology : 69 -78.
Yue, P., Jin, H., Aillaud, M., Deng, A.C., Azuma, J., Asagami, T., Kundu, R.K., Reaven, G.M., Quertermous, T. and Tsao, P.S., 2010. Apelin is necessary for the maintenance of insulin sensitivity. American Journal of Physiology - Endocrinology and Metabolism 298: E59-E67.
'Apelin is necessary for the maintenance of insulin sensitivity ' () 298 American Journal of Physiology - Endocrinology and Metabolism : E59 -E67.
Zhou, J., Martin, R.J., Tulley, R.T., Raggio, A.M., McCutcheon, K.L., Shen, L., Danna, S.C., Tripathy, S., Hegsted, M. and Keenan, M.J., 2008. Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. American Journal of Physiology - Endocrinology and Metabolism 295: E1160-E1166.
'Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents ' () 295 American Journal of Physiology - Endocrinology and Metabolism : E1160 -E1166.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 1541 | 524 | 36 |
| PDF Views & Downloads | 1163 | 374 | 16 |
Crosstalk between organs is crucial for controlling numerous homeostatic systems (e.g. energy balance, glucose metabolism and immunity). Several pathological conditions, such as obesity and type 2 diabetes, are characterised by a loss of or excessive inter-organ communication that contributes to the development of disease. Recently, we and others have identified several mechanisms linking the gut microbiota with the development of obesity and associated disorders (e.g. insulin resistance, type 2 diabetes, hepatic steatosis). Among these, we described the concept of metabolic endotoxaemia (increase in plasma lipopolysaccharide levels) as one of the triggering factors leading to the development of metabolic inflammation and insulin resistance. Growing evidence suggests that gut microbes contribute to the onset of low-grade inflammation characterising these metabolic disorders via mechanisms associated with gut barrier dysfunctions. We have demonstrated that enteroendocrine cells (producing glucagon-like peptide-1, peptide YY and glucagon-like peptide-2) and the endocannabinoid system control gut permeability and metabolic endotoxaemia. Recently, we hypothesised that specific metabolic dysregulations occurring at the level of numerous organs (e.g. gut, adipose tissue, muscles, liver and brain) rely from gut microbiota modifications. In this review, we discuss the mechanisms linking gut permeability, adipose tissue metabolism, and glucose homeostasis, and recent findings that show interactions between the gut microbiota, the endocannabinoid system and the apelinergic system. These specific systems are discussed in the context of the gut-to-peripheral organ axis (intestine, adipose tissue and brain) and impacts on metabolic regulation. In the present review, we also briefly describe the impact of a variety of non-digestible nutrients (i.e. inulin-type fructans, arabinoxylans, chitin glucans and polyphenols). Their effects on the composition of the gut microbiota and activity are discussed in the context of obesity and type 2 diabetes.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 1541 | 524 | 36 |
| PDF Views & Downloads | 1163 | 374 | 16 |